Anderson H - Search Results

1

Five year follow-up and dose delivery analysis of cisplatin, iproplatin or carboplatin in combination with cyclophosphamide in advanced ovarian carcinoma.

Gurney H, Crowther D, Anderson H, Murphy D, Prendiville J, Ranson M, Mayor P, Swindell R, Buckley CH, Tindall VR. Gurney H, et al. Among authors: anderson h. Ann Oncol. 1990 Nov;1(6):427-33. Ann Oncol. 1990. PMID: 2083186 Free article. Clinical Trial.

2

A randomised study of adjuvant MVPP chemotherapy after mantle radiotherapy in pathologically staged IA-IIB Hodgkin's disease: 10-year follow-up.

Anderson H, Crowther D, Deakin DP, Ryder WD, Radford JA. Anderson H, et al. Ann Oncol. 1991 Feb;2 Suppl 2:49-54. doi: 10.1007/978-1-4899-7305-4_8. Ann Oncol. 1991. PMID: 2049321 Free article. Clinical Trial.

3

The role of postoperative alkylating agent therapy in early-stage epithelial ovarian cancer.

Mackintosh J, Buckley CH, Tindall VR, Lind MJ, Anderson H, Crowther D. Mackintosh J, et al. Among authors: anderson h. Br J Obstet Gynaecol. 1989 Mar;96(3):353-7. doi: 10.1111/j.1471-0528.1989.tb02397.x. Br J Obstet Gynaecol. 1989. PMID: 2713294

4

Comparative toxicity of cisplatin, carboplatin (CBDCA) and iproplatin (CHIP) in combination with cyclophosphamide in patients with advanced epithelial ovarian cancer.

Anderson H, Wagstaff J, Crowther D, Swindell R, Lind MJ, McGregor J, Timms MS, Brown D, Palmer P. Anderson H, et al. Eur J Cancer Clin Oncol. 1988 Sep;24(9):1471-9. doi: 10.1016/0277-5379(88)90338-0. Eur J Cancer Clin Oncol. 1988. PMID: 3053207 Clinical Trial.

5

Chemotherapy in non-small cell lung cancer.

Thatcher N, Ranson M, Lee SM, Niven R, Anderson H. Thatcher N, et al. Among authors: anderson h. Ann Oncol. 1995;6 Suppl 1:83-94; discussion 94-5. doi: 10.1093/annonc/6.suppl_1.s83. Ann Oncol. 1995. PMID: 8695551 Review.

6

Randomised phase II study of cisplatin-etoposide versus infusional carboplatin in advanced non-small-cell lung cancer and mesothelioma.

White SC, Anderson H, Jayson GC, Ashcroft L, Ranson M, Thatcher N. White SC, et al. Among authors: anderson h. Ann Oncol. 2000 Feb;11(2):201-6. doi: 10.1023/a:1008328605413. Ann Oncol. 2000. PMID: 10761756 Free article. Clinical Trial.

7

Recombinant human GM-CSF in small cell lung cancer: a phase I/II study.

Anderson H, Gurney H, Thatcher N, Swindell R, Scarffe JH, Weiner J. Anderson H, et al. Recent Results Cancer Res. 1991;121:155-61. doi: 10.1007/978-3-642-84138-5_17. Recent Results Cancer Res. 1991. PMID: 1650015 Clinical Trial.

8

A randomised study of intravenous bolus versus continuous infusion of ifosfamide and doxorubicin with oral etoposide for small-cell lung cancer.

Anderson H, Prendiville J, Thatcher N, Radford JA, Swindell R. Anderson H, et al. J Cancer Res Clin Oncol. 1991;117 Suppl 4:S139-40. doi: 10.1007/BF01613219. J Cancer Res Clin Oncol. 1991. PMID: 1665490 Clinical Trial.

9

MMAF for advanced gastric cancer.

Anderson H, Scarffe JH, Ranson M, Kamthan AG, Dougal M, Russell SA, Wilkinson MJ, Ostick DG. Anderson H, et al. Eur J Cancer. 1991;27(10):1234-8. doi: 10.1016/0277-5379(91)90088-u. Eur J Cancer. 1991. PMID: 1835592

10

Therapy for poor-risk patients with small-cell lung cancer using bolus ifosfamide and oral etoposide.

Anderson H, Lind MJ, Thatcher N, Swindell R, Woodcock A, Carroll KB. Anderson H, et al. Cancer Chemother Pharmacol. 1990;26(1):71-4. doi: 10.1007/BF02940299. Cancer Chemother Pharmacol. 1990. PMID: 2157555

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,123 results

Search Page

Filters